Zahn becomes director of ped card at Cedars

pediatric cardiology - 272.44 Kb
Evan M. Zahn, MD Source: Cedars-Sinai Heart Institute
Evan M. Zahn, MD, has joined the Cedars-Sinai Heart Institute in Los Angeles to focus on the study of congenital heart disease and develop more minimally invasive treatments for the program. As director of pediatric cardiology at the Cedars-Sinai Heart Institute and director of its congenital heart disease program, he will diagnose and treat children born with heart defects such as hypoplastic left heart syndrome and tetralogy of Fallot.

Zahn also will be establishing a program aimed at treating adult patients with congenital heart issues.   

He joined Cedars-Sinai after serving as chief of cardiology at Miami Children's Hospital. Zahn also directed Miami Children’s interventional catheterization program and performed the world’s first nonsurgical tricuspid valve replacement via catheter on a 9-year-old boy. 

Zahn received a bachelor’s degree in biology at the State University of New York at Albany before earning his medical degree from New York Medical College in Valhalla. He completed his pediatric training at the University of Colorado’s Affiliated Hospitals in Denver. 

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.